{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:16:12Z","timestamp":1778706972986,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Thessaly Central Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psoriasis and psoriatic arthritis (PsA) are chronic inflammatory diseases, recognized as one entity, termed psoriatic disease (PsD). CD39 is an ectonucleotidase that hydrolyzes ATP to adenosine and is expressed on a human Treg sub-population capable of exerting interleukin (IL-) 17 suppression. We aimed to investigate the effect of apremilast on CD39 expression in T cells from patients with PsD. Peripheral blood mononuclear cells (PBMCs) were analyzed by multicolor flow cytometry and appropriate monoclonal antibodies. Intracellular cytokine production of PBMCs was measured after in vitro PMA plus ionomycin stimulation. At 6\u00a0weeks post-treatment\n                    <jats:bold>,<\/jats:bold>\n                    apremilast inhibited IL-17 and interferon-\u03b3 (IFN\u03b3) production, increased IL-10 production in both CD4+T cells and CD4-T cells, and inhibited IL-6 production in CD4-T cells. At baseline, levels of CD4+CD39+\u2009cells were decreased in patients compared to controls. At 6\u00a0weeks post-treatment, CD4+CD39+\u2009cells increased. Furthermore, CD4+CD39+ cells producing IL-10 increased in patients who achieved a PASI response. A significant proportion of IL-10-producing CD39+ cells were CD56-CD11c- cells. CD4+FoxP3+ cells were decreased in patients compared to controls. At 6\u00a0weeks post-treatment CD4+FoxP3+ cells, and CD4+FoxP3+CD39+\u2009cells increased, although CD4+CD25hiFoxP3+ Treg cells did not change significantly. If confirmed in larger studies, CD4+CD39+ cells producing IL-10 could likely become associated with the response to apremilast.\n                  <\/jats:p>","DOI":"10.1007\/s00296-026-06114-3","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:48:59Z","timestamp":1778042939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apremilast therapy increases CD39+CD4+ T cells in peripheral blood of patients with psoriatic disease: a retrospective observational pilot study"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-1323","authenticated-orcid":false,"given":"Athanasios","family":"Mavropoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-7281","authenticated-orcid":false,"given":"Sotirios G.","family":"Tsiogkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-5090","authenticated-orcid":false,"given":"Theodora","family":"Simopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2957-641X","authenticated-orcid":false,"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-7292","authenticated-orcid":false,"given":"Efterpi","family":"Zafiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7670-3314","authenticated-orcid":false,"given":"Lazaros I.","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-7902","authenticated-orcid":false,"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"6114_CR1","doi-asserted-by":"publisher","first-page":"114624","DOI":"10.1016\/j.intimp.2025.114624","volume":"155","author":"M Hassan","year":"2025","unstructured":"Hassan M, Elzallat M, Mohammed DM, Balata M, El-Maadawy WH (2025) Exploiting regulatory T cells (Tregs): cutting-edge therapy for autoimmune diseases. Int Immunopharmacol 155:114624","journal-title":"Int Immunopharmacol"},{"key":"6114_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-020-0304-7","volume":"16","author":"KM Dwyer","year":"2020","unstructured":"Dwyer KM, Kishore BK, Robson SC (2020) Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nat Rev Nephrol 16:509\u2013524. https:\/\/doi.org\/10.1038\/s41581-020-0304-7","journal-title":"Nat Rev Nephrol"},{"key":"6114_CR3","first-page":"2410","volume":"10","author":"JL Mcrae","year":"2011","unstructured":"Mcrae JL, Winterhalter A, Doherty G, Deaglio S (2011) Expression of CD39 by human peripheral blood CD4+CD25+ T cells denotes a regulatory memory phenotype. Am J Transpl 10:2410\u20132420","journal-title":"Am J Transpl"},{"key":"6114_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/cmi.2016.30","volume":"14","author":"J Gu","year":"2017","unstructured":"Gu J, Ni X, Pan X, Lu H, Lu Y, Zhao J et al (2017) Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions. Cell Mol Immunol 14:521\u2013528. https:\/\/doi.org\/10.1038\/cmi.2016.30","journal-title":"Cell Mol Immunol"},{"key":"6114_CR5","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.3390\/ijms24054348","volume":"24","author":"I Pietraforte","year":"2023","unstructured":"Pietraforte I, Frasca L (2023) Autoreactive T-cells in psoriasis: are they spoiled tregs and can therapies restore their functions? Int J Mol Sci 24:4348","journal-title":"Int J Mol Sci"},{"key":"6114_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autrev.2016.09.015","volume":"16","author":"LI Sakkas","year":"2017","unstructured":"Sakkas LI, Bogdanos DP (2017) Are psoriasis and psoriatic arthritis the same disease? the IL-23\/IL-17 axis data. Autoimmun Rev 16:10\u201315","journal-title":"Autoimmun Rev"},{"key":"6114_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","volume":"7","author":"O FitzGerald","year":"2021","unstructured":"FitzGerald O, Ogdie A, Chandran V, Coates LC, Kavanaugh A, Tillett W et al (2021) Psoriatic arthritis. Nat Rev Dis Prim 7:59. https:\/\/doi.org\/10.1038\/s41572-021-00293-y","journal-title":"Nat Rev Dis Prim"},{"key":"6114_CR8","doi-asserted-by":"publisher","unstructured":"Di Meglio P, Villanova F, Nestle FO (2014) Psoriasis. Cold Spring Harb Perspect Med 4 https:\/\/doi.org\/10.1101\/cshperspect.a015354","DOI":"10.1101\/cshperspect.a015354"},{"key":"6114_CR9","doi-asserted-by":"publisher","first-page":"1346757","DOI":"10.3389\/fmed.2024.1346757","volume":"11","author":"B Lob\u00e3o","year":"2024","unstructured":"Lob\u00e3o B, Louren\u00e7o D, Giga A, Mendes-Bastos P (2024) From PsO to PsA: the role of T(RM) and Tregs in psoriatic disease, a systematic review of the literature. Front Med 11:1346757","journal-title":"Front Med"},{"key":"6114_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2230.2004.01638.x","volume":"29","author":"Y Teraki","year":"2004","unstructured":"Teraki Y, Miyake A, Takebayashi R, Shiohara T (2004) Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 29:658\u2013663","journal-title":"Clin Exp Dermatol"},{"key":"6114_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R et al (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 110:1225\u20131232","journal-title":"Blood"},{"key":"6114_CR12","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","volume":"183","author":"JM Fletcher","year":"2009","unstructured":"Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O\u2019Farrelly C et al (2009) CD39 + Foxp3 + regulatory T cells suppress pathogenic Th17 cells and are impaired in Multiple Sclerosis. J Immunol 183:7602\u20137610","journal-title":"J Immunol"},{"key":"6114_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/jir.2016.0071","volume":"37","author":"JR Magid-Bernstein","year":"2017","unstructured":"Magid-Bernstein JR, Rohowsky-Kochan CM (2017) Human CD39+ Treg cells express Th17-associated surface markers and suppress IL-17 via a Stat3-dependent mechanism. J Interferon Cytokine Res 37:153\u2013164","journal-title":"J Interferon Cytokine Res"},{"key":"6114_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s40265-015-0439-1","volume":"75","author":"ED Deeks","year":"2015","unstructured":"Deeks ED (2015) Apremilast: a review in psoriasis and psoriatic arthritis. Drugs 75:1393\u20131403","journal-title":"Drugs"},{"key":"6114_CR15","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/rheumatology\/kez204","volume":"58","author":"A Mavropoulos","year":"2019","unstructured":"Mavropoulos A, Zafiriou E, Simopoulou T, Brotis AG, Liaskos C, Roussaki-Schulze A et al (2019) Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis. Rheumatology (Oxford) 58:2240\u20132250","journal-title":"Rheumatology (Oxford)"},{"key":"6114_CR16","doi-asserted-by":"publisher","first-page":"108513","DOI":"10.1016\/j.clim.2020.108513","volume":"218","author":"H Dai","year":"2020","unstructured":"Dai H, Adamopoulos IE (2020) Psoriatic arthritis under the influence of IFN\u03b3. Clin Immunol 218:108513","journal-title":"Clin Immunol"},{"key":"6114_CR17","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T (2010) IL-6: regulator of Treg\/Th17 balance. Eur J Immunol 40:1830\u20131835","journal-title":"Eur J Immunol"},{"key":"6114_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00296-009-0949-9","volume":"30","author":"C Dejaco","year":"2010","unstructured":"Dejaco C, Duftner C, Klauser A, Schirmer M (2010) Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica. Rheumatol Int 30:297\u2013303. https:\/\/doi.org\/10.1007\/s00296-009-0949-9","journal-title":"Rheumatol Int"},{"key":"6114_CR19","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00296-010-1427-0","volume":"31","author":"M Habibagahi","year":"2011","unstructured":"Habibagahi M, Habibagahi Z, Jaberipour M, Aghdashi A (2011) Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus. Rheumatol Int 31:1219\u20131225. https:\/\/doi.org\/10.1007\/s00296-010-1427-0","journal-title":"Rheumatol Int"},{"key":"6114_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00296-010-1728-3","volume":"32","author":"A Stelmaszczyk-Emmel","year":"2012","unstructured":"Stelmaszczyk-Emmel A, Jackowska T, Rutkowska-Sak L, Marusak-Banacka M, W\u0105sik M (2012) Identification, frequency, activation and function of CD4+ CD25highFoxP3+\u00a0regulatory T cells in children with juvenile idiopathic arthritis. Rheumatol Int 32:1147\u20131154. https:\/\/doi.org\/10.1007\/s00296-010-1728-3","journal-title":"Rheumatol Int"},{"key":"6114_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2011.09.013","volume":"240\u2013241","author":"E Peelen","year":"2011","unstructured":"Peelen E, Damoiseaux J, Smolders J, Knippenberg S, Menheere P, Tervaert JWC et al (2011) Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. J Neuroimmunol 240\u2013241:97\u2013103","journal-title":"J Neuroimmunol"},{"key":"6114_CR22","doi-asserted-by":"publisher","first-page":"16788","DOI":"10.1073\/pnas.0902869106","volume":"106","author":"DJ Friedman","year":"2009","unstructured":"Friedman DJ, K\u00fcnzli BM, A-Rahim YI, Sevigny J, Berberat PO, Enjyoji K, et al (2009) From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci USA 106:16788\u201316793","journal-title":"Proc Natl Acad Sci USA"},{"key":"6114_CR23","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1111\/ajd.12561","volume":"59","author":"L Han","year":"2018","unstructured":"Han L, Sugiyama H, Zhang Q, Yan K, Fang X, McCormick TS et al (2018) Phenotypical analysis of ectoenzymes CD39\/CD73 and adenosine receptor 2A in CD4+CD25highFoxp3+ regulatory T-cells in psoriasis. Australas J Dermatol 59:e31\u2013e38","journal-title":"Australas J Dermatol"},{"key":"6114_CR24","doi-asserted-by":"publisher","first-page":"110728","DOI":"10.1016\/j.celrep.2022.110728","volume":"39","author":"MC Glass","year":"2022","unstructured":"Glass MC, Glass DR, Oliveria JP, Mbiribindi B, Esquivel CO, Krams SM et al (2022) Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets. Cell Rep 39:110728. https:\/\/doi.org\/10.1016\/j.celrep.2022.110728","journal-title":"Cell Rep"},{"key":"6114_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00296-012-2365-9","volume":"33","author":"JS Oh","year":"2013","unstructured":"Oh JS, Kim Y-G, Lee SG, So MW, Choi SW, Lee C-K et al (2013) The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4+CD25+ regulatory T cells. Rheumatol Int 33:381\u2013388. https:\/\/doi.org\/10.1007\/s00296-012-2365-9","journal-title":"Rheumatol Int"},{"key":"6114_CR26","first-page":"1","volume":"2014","author":"Y Lu","year":"2014","unstructured":"Lu Y, Wang J, Gu J, Lu H, Li X, Qian X et al (2014) Rapamycin regulates iTreg function through CD39 and Runx1 pathways. J Immunol Res 2014:1\u20139","journal-title":"J Immunol Res"},{"key":"6114_CR27","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1073\/pnas.1424792112","volume":"112","author":"RS Peres","year":"2015","unstructured":"Peres RS, Liew FY, Talbot J, Carregaro V, Oliveira RD, Almeida SL et al (2015) Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc Natl Acad Sci USA 112:2509\u20132514","journal-title":"Proc Natl Acad Sci USA"},{"key":"6114_CR28","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1111\/1756-185X.13333","volume":"21","author":"V Gupta","year":"2018","unstructured":"Gupta V, Katiyar S, Singh A, Misra R, Aggarwal A (2018) CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis. Int J Rheum Dis 21:1548\u20131556","journal-title":"Int J Rheum Dis"},{"key":"6114_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00296-019-04344-2","volume":"39","author":"A Singh","year":"2019","unstructured":"Singh A, Misra R, Aggarwal A (2019) Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis. Rheumatol Int 39:1431\u20131438. https:\/\/doi.org\/10.1007\/s00296-019-04344-2","journal-title":"Rheumatol Int"},{"key":"6114_CR30","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1038\/s41598-022-24924-w","volume":"12","author":"JN Pouw","year":"2022","unstructured":"Pouw JN, Olde Nordkamp MAM, van Kempen T, Concepcion AN, van Laar JM, van Wijk F et al (2022) Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + ROR\u03b3t + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies. Sci Rep 12:20675. https:\/\/doi.org\/10.1038\/s41598-022-24924-w","journal-title":"Sci Rep"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06114-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06114-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06114-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:02:49Z","timestamp":1778706169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06114-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6114"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06114-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (December 2024 version) and was approved by the Ethics Committee of the University General Hospital of Larissa, University of Thessaly (protocol 41636\/01-10-19 & 20931\/11-06-2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Each participant involved in the study provided an informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"84"}}